PEB - Pacific Edge Ltd

[drcjp]

I would love the chance to charge $235 a test....

[drcjp]

Operating revenue of $3.4m with one year to go to get the US$100m target - HUMBUG!

Yeah granted in this case, but it can happen. Thanks to statins, CRP went from $10M p.a. to $120M p.a. in 2 years.

PEB really need to find a companion status for their test as well.

[kiwidollabill]

wow...... I've been a bit of a critic over time but I never thought it was this bad.... the difference between 8.1M and 3.2M isnt just creative accounting in anticipation of rev, its outright lying about the state of the company. I'd be interested in seeing the FY16 corrected numbers, has there been essentially no cash growth in 24 months?

[Balance]

wow...... I've been a bit of a critic over time but I never thought it was this bad.... the difference between 8.1M and 3.2M isnt just creative accounting in anticipation of rev, its outright lying about the state of the company. I'd be interested in seeing the FY16 corrected numbers, has there been essentially no cash growth in 24 months?

https://www.pacificedgedx.com/assets...EPORT-2016.pdf

Can work back from 2016 accounts which showed accounts receivable of $5.73m but is now restated at $1.46m - a drop of $4.27m.

Revenue showed in 2016 accounts was $4.98m.

Simplistically, it means that PEB did not even generated $1m of real revenues in 2016.

[Balance]

https://www.pacificedgedx.com/assets...EPORT-2016.pdf

Can work back from 2016 accounts which showed accounts receivable of $5.73m but is now restated at $1.46m - a drop of $4.27m.

Revenue showed in 2016 accounts was $4.98m.

Simplistically, it means that PEB did not even generated $1m of real revenues in 2016.

Means after proclaiming to all and sundry that PEB made its first commercial in the US in October 2013 (yes, nearly 3 years ago), PEB did not even sell 5,000 tests or $1m of real sales in 2016!

So much for all the bullish announcements and positive progresses made by this company in the last 5 years!

What credibility has this company got left when it comes to the market for more cash - what's left in the balance sheet as at 31 March 2018 is enough to last just another 10 months of cash burn from now.

[Ggcc]

I see this company looking more
Like a takeover target, if the technology is so fantastic. I would not have a clue at the price they would want to pay for it, but US companies with deep pockets might find PEB very good to add to their other products. I would not expect to see an offer greater than 60-70 cents per share though. Just my thought of the day.

[Balance]

I see this company looking more
Like a takeover target, if the technology is so fantastic. I would not have a clue at the price they would want to pay for it, but US companies with deep pockets might find PEB very good to add to their other products. I would not expect to see an offer greater than 60-70 cents per share though. Just my thought of the day.

So you think there is a company out there will pay:

$280m to $325m

for a product which has singularly failed to get traction after having over a hundred million dollars thrown at the commercialization program in the last 5 years?

I held the view which was challenged by some on this site that PEB has been one of the most dishonest company with its announcements in the market.

Today's announcement of non-existent revenues in 2016 confirms my view imo.

There is but one hope left for PEB - it is to team up with an existing player with established distribution channels (J & J for eg) and cut operating expenses to less than $5m a year.

Start by getting rid of the existing management.

[winner69]

Chemists usually pretty good at magical jiggery pokery stuff ....when it comes to accounting they do it even better than artists

[forest]

So you think there is a company out there will pay:

$280m to $325m

for a product which has singularly failed to get traction after having over a hundred million dollars thrown at the commercialization program in the last 5 years?

I held the view which was challenged by some on this site that PEB has been one of the most dishonest company with its announcements in the market.

Today's announcement of non-existent revenues in 2016 confirms my view imo.

There is but one hope left for PEB - it is to team up with an existing player with established distribution channels (J & J for eg) and cut operating expenses to less than $5m a year.

Start by getting rid of the existing management.

I agree with most of what you say about PEB Balance.
The previous Chairman Chris Swann was clearly out of his dept chairing this company.
However under the present Chairman Chris Gallaher the accounting system has been changed for the better. Should we give the present chair some more time to prove himself?
I am not following this company very closely lately so have no opinion on this.

[Ggcc]

So you think there is a company out there will pay:

$280m to $325m

for a product which has singularly failed to get traction after having over a hundred million dollars thrown at the commercialization program in the last 5 years?

I held the view which was challenged by some on this site that PEB has been one of the most dishonest company with its announcements in the market.

Today's announcement of non-existent revenues in 2016 confirms my view imo.

There is but one hope left for PEB - it is to team up with an existing player with established distribution channels (J & J for eg) and cut operating expenses to less than $5m a year.

Start by getting rid of the existing management.

If what they say about their products being fantastic and how far ahead they are of any competition out there is correct, then the issue becomes a management problem not a product problem.

Then with the correct management, any fantastic product would take off with the right push.

The idea of any offer lower than 60-70 cents per share would mean that negotiations would take too long before any investors could get their hands on this (fantastic) product.

That is where I got my valuation.